跳至主要内容
临床试验/CTRI/2019/03/018132
CTRI/2019/03/018132已完成1/2 期

Randomized Controlled Clinical Trial To Evaluate Efficacy Of ‘Draksha Sharkar’ And ‘Darvi Amalaki Sharkar’ In ‘Pittaj Mootrakrichchhra’.

Sumatibhai Shah Ayurved Mahavidyalaya1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年3月18日最近更新:

试验速览

阶段
1/2 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
1) To assess the efficacy of ‘Draksha Sharkar’ in ‘Pittaj mootrakrichchhra’ by clinical parameter (Lakshana).

研究概览

简要总结

RandomizedControlled Clinical Trial To Evaluate Efficacy Of ‘Draksha Sharkar’ And ‘Darvi Amalaki Sharkar’ In ‘Pittaj Mootrakrichchhra’

Primary : To assess the efficacy of ‘DrakshaSharkar’ in ‘Pittaj mootrakrichchhra’ by clinical parameter(Lakshana) and by Routine examinationof urine.

Selectionof topic : This study is plannedto assess the efficacy of Draksha Sharkaron pittaj mootrakrichchhra and to provide better option for its management. Indeveloping country disease has more prevalence due to poor personal hygiene,mal nutrition, and environmental condition. Pittaj**mootrakrichchhra is a disease where ayurveda offer a better hand than anyother medical system. Scope of present work is limited upto pittaj mootrakrichchhraonly. Recurrence of disease is very common. Hence, this subject is consideringfor study, to assess the efficacy of DrakshaSharkar in pittaj mootrakrichchhra.

*considering all the above things the study will be carried out in comparison between two ayurvedic formulations. Patients will be divided into 2 groups containing 30 each. 1 group will be given Draksha Sharkar and other group will be given Darvi Amalaki Sharkar.*Urine routine will be done on 1st and 5th day. Results and conclusion will be drawn from the observations made during the study.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients presenting with cardinal symptoms of Pittaj mootrakrichchhra mentioned in Charak Samhita, chikitsasthan
  • Such as 1.Sapeetamutrapravrutti 2.Saraktamutra pravrutti 3.Muhurmuhu mutra pravrutti 4.Sadaha Mutrapravritti 5.Sashul Mutrapravritti 2) The patients will be selected irrespective of religion, occupation, economical status and marital status with informed written consent.
  • Patient having above 2 or more than complaints will be selected.

排除标准

  • Diagnosed patient of 1.Uncontrolled Diabetes Mellitus and Known case of diabetes mellitus 2.TB 3.Renal failure.
  • 4.Patient of chronic cystitis with bladder wall change.
  • 5.Benign or malignant tumors of bladder 6.Known cases of HIV infection.
  • 7.Known case of mutraghat, ashmari (renal, vesicular calculus), benign prostate hypertrophy, urethral stricture, phimosis, tumours, trauma to urogenital tract.
  • 8.Congenital causes and Obstructive pathology.

结局指标

主要结局

1) To assess the efficacy of ‘Draksha Sharkar’ in ‘Pittaj mootrakrichchhra’ by clinical parameter (Lakshana).

时间窗: 5 Days

2) To assess the efficacy of ‘Draksha Sharkar’ in ‘Pittaj mootrakrichchhra’ by Routine examination of urine.

时间窗: 5 Days

次要结局

  • 1. To develop evidence based research for efficacy of ‘Draksha Sharkar’ in ‘Pittaj mootrakrichchhra’(2. To generate data of good standardized drug of herbal origin with good efficacy and less side effects.)

研究者

发起方
Sumatibhai Shah Ayurved Mahavidyalaya
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验